AbbVie (ABBV) EBT Margin (2012 - 2026)
AbbVie (ABBV) recorded EBT Margin of 27.75% in Q3 2026, up 23.22 percentage points from 4.53% a year earlier and up 2.57 percentage points from the prior quarter.
Powered by 
Analysis
AbbVie (ABBV) EBT Margin (2012 - 2026) Analysis & Trends
On a TTM basis, AbbVie's EBT Margin came in at 19.41% as of Sep 30, 2026, up 16.63 percentage points year-over-year; for FY2025, it came in at 10.79%, up 4.19 percentage points from FY2024.
- Annual EBT Margin has a five-year change of +3.37 percentage points (FY2020 to FY2025).
- Across earlier years, EBT Margin came in at 6.60% in FY2024 (-4.91 pp), 11.51% in FY2023 (-11.71 pp), 23.21% in FY2022 (+0.10 pp) and 23.11% in FY2021 (+15.69 pp).
- The Q3 2026 figure is the highest quarterly EBT Margin since Q3 2022.
- On a year-over-year basis, EBT Margin rose in three of the last eight quarters, with an average year-over-year change of +2.99 percentage points.
- Peak year-over-year performance for EBT Margin in the last five years was a gain of 39.57 percentage points in Q4 2021, against a drop of 32.52 percentage points in Q1 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at 25.18% (Q2 2026), 6.93% (Q1 2026) and 16.05% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 0.13% |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 27.75% |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 26.27% |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 45.21% |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 36.90% |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 20.41% |
| 10 | Vertex Pharmaceuticals | 136.55 Bn | 104.28 Bn | 2.91 Bn | 22.77% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 27.75% |
| Jun 30, 2026 | 25.18% |
| Mar 31, 2026 | 6.93% |
| Dec 31, 2025 | 16.05% |
| Sep 30, 2025 | 4.53% |
| Jun 30, 2025 | 10.08% |
| Mar 31, 2025 | 12.45% |
| Dec 31, 2024 | -15.02% |
| Sep 30, 2024 | 14.41% |
| Jun 30, 2024 | 14.84% |
| Mar 31, 2024 | 14.26% |
| Dec 31, 2023 | 8.47% |
| Sep 30, 2023 | 14.02% |
| Jun 30, 2023 | 18.82% |
| Mar 31, 2023 | 3.89% |
| Dec 31, 2022 | 19.61% |
| Sep 30, 2022 | 29.71% |
| Jun 30, 2022 | 8.11% |
| Mar 31, 2022 | 36.41% |
| Dec 31, 2021 | 28.69% |
API Access
AbbVie EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=ABBV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "ABBV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=ABBV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();